Back to Authors

Tilt, Nicola

0009-0003-4397-6329

A5080692753 | I4210134054

Mayo Clinic

UCB Pharma (United Kingdom)

Citations 1

Bimekizumab 2‐year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results

Journal of the European Academy of Dermatology and Venereology | July 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/jdv.70631 | PMID 42482599